Safety and efficacy of efalizumab in combination with methotrexate in patients with severe psoriasis: a comparative study.

Trial Profile

Safety and efficacy of efalizumab in combination with methotrexate in patients with severe psoriasis: a comparative study.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 24 May 2012

At a glance

  • Drugs Efalizumab; Methotrexate
  • Indications Plaque psoriasis
  • Focus Adverse reactions
  • Most Recent Events

    • 24 May 2012 Company (Serono Europe) added to the associations field as reported by European Clinical Trials Database record.
    • 17 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top